Search Results 1161-1170 of 18128 for monoclonal antibody

  1. Assessment Of Biomarker-Guided CNI Substitution In Kidney Transplantation - Mayo Clinic

    Current use of immunomodulatory agents (including but not limited to: Rituximab, anti-Tumor necrosis factor(TNF) Monoclonal antibodies (mAb), or Belatacept, ...

  2. Cholangiocarcinoma (Bile Duct Cancer) Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as atezolizumab, may interfere with the ability of tumor cells to grow and spread. Cobimetinib may stop the growth of tumor ...

  3. GEN3013, Epcoritamab Trial In Patients With Relapsed, Progressive Or Refractory B-Cell Lymphoma EPCORE™ NHL-1 - Mayo Clinic

    Relapsed, progressive and/or refractory disease following treatment with an anti-CD20 monoclonal antibody (e.g., rituximab) potentially in combination with ...

  4. Efficacy And Safety Study Of Benralizumab To Reduce OCS Use In Patients With Uncontrolled Asthma On High Dose Inhaled Corticosteroid Plus LABA And Chronic OCS Therapy - Mayo Clinic

    We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the ...

  5. A Study To Evaluate The Efficacy And Safety Of Rozanolixizumab In Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD) - Mayo Clinic

    A Study To Evaluate The Efficacy And Safety Of Rozanolixizumab In Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease ...

  6. A Safety And Efficacy Study Of Treatment Combinations With And Without Chemotherapy In Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

    * Discontinued use of prior immune checkpoint therapy due to immune related adverse events; received prior treatment with an anti-TIGIT monoclonal antibody.

  7. Atezolizumab Immunotherapy In Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

    Prior severe infusion reaction to a monoclonal antibody. Severe, active co-morbidity, defined as follows: Significant history of uncontrolled cardiac ...

  8. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...

  9. Cancer treatment - Doctors & Departments - Mayo Clinic

    Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · Multiple myeloma · Myxofibrosarcoma ...

  10. Bone Marrow Transplant Clinical Trials - Mayo Clinic Research

    Radioactive substances linked to monoclonal antibodies, such as 90-yttrium ibritumomab tiuxetan, can bind to cancer cells and give off radiation which may help ...